<DOC>
	<DOCNO>NCT00536380</DOCNO>
	<brief_summary>This study investigate effectiveness desloratadine dose high ( 10 mg 20 mg ) currently approve ( 5 mg ) treatment chronic idiopathic urticaria . Subjects chronic urticaria currently take second generation antihistamine treat desloratadine ( 5 , 10 , 20 mg ) 28 day .</brief_summary>
	<brief_title>Study Treatment Chronic Idiopathic Urticaria With High Doses AERIUS ( Desloratadine ) ( Study P04849 )</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Subjects must satisfy follow criterion enrolled/randomized study . Subject must demonstrate willingness participate study . Subject must 18 75 year age , either gender , race . Subject must episode chronic idiopathic urticaria least 6 week , dose `` 2nd generation antihistamine ( AH ) '' 2 week longer , Subject 's current episode urticaria sufficiently symptomatic Screening Visit qualify study , opinion investigator . Subject Baseline Week ( entry period ) UAS 10 30 inclusive . Patient must understand willing ass record symptom score . Has voluntarily sign write informed consent . Subjects must confirm prior medication washout time observe . Subject must confirm he/she practice adequate contraception : Female volunteer childbearing potential ( include woman less 1 year postmenopausal woman sexually active study ) must agree use medically accept method contraception surgically sterilize prior screen , receive protocolspecified medication , 30 day stop medication . Women postmenopausal &gt; 1 year ( i.e. , woman experience 12 consecutive month amenorrhea ) exempt use contraception study . Nonsterile premenopausal female subject must use medically accept method birth control , ie , doublebarrier method ( eg , male female condom spermicide ) , oral contraceptive , DepoProvera , NuvaRing , contraceptive transdermal patch , etc , female subject childbearing potential prior screening study . Women childbearing potential counseled appropriate use birth control study . Vasectomy tubal ligation consider single barrier . Women currently sexually active must agree consent use one abovementioned method become sexually active participate study . If subject female volunteer childbearing potential , must negative urine pregnancy test Screening/Visit 1 . Subjects must free clinically relevant disease chronic idiopathic urticaria ( CIU ) would , principal investigator 's and/or sponsor 's opinion , interfere conduct study study evaluation . Subjects must able adhere dose visit schedule agree record symptom severity score , medication time , concomitant medication , adverse event ( AEs ) accurately consistently daily diary . Is female pregnant , intend become pregnant study . Is nurse , intend nursing study within 90 day study completion . Has observe designate washout period prohibit medication . Has use investigational product within 30 day prior enrollment . Have follow clinical condition : Symptomatic seasonal perennial allergic rhinitis . Asthma control shortacting beta2 agonist use necessary . The presence permanent severe disease , especially affect immune system , except urticaria . The presence permanent gastrointestinal condition may influence oral therapy ( chronic diarrhea disease , congenital malformation surgical mutilation gastrointestinal tract ) . History of/or presence epilepsy , significant neurological disorder , cerebrovascular attack ischemia . History of/or presence myocardial infarction cardiac arrhythmia require drug therapy . Evidence of/or history significant renal disease . Evidence of/or history significant hepatic disease . Presence cancer require chemotherapy radiation therapy . Presence glaucoma . Presence urinary bladder neck obstruction empty difficulty . Presence acute urticaria . Body mass index ( BMI ) &gt; 35 Has clinically significant deviation appropriate reference range physical examination , clinical evaluation , investigator 's judgment , may interfere study evaluation affect subject safety . Is situation condition , opinion investigator , may interfere optimal participation study . Is participate clinical study ( y ) . Is staff , affiliate , family member staff personnel directly involve study . Is allergic history hypersensitivity study drug ( desloratadine ) , excipients , loratadine . Has rare hereditary problem galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>